Pacira BioSciences Inc (PCRX)
25.90
-0.91
(-3.39%)
USD |
NASDAQ |
Apr 24, 16:00
25.91
+0.01
(+0.04%)
After-Hours: 20:00
Pacira BioSciences Free Cash Flow (Quarterly): 45.79M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 45.79M |
| September 30, 2023 | 41.04M |
| June 30, 2023 | 40.10M |
| March 31, 2023 | 12.56M |
| December 31, 2022 | 36.54M |
| September 30, 2022 | 37.47M |
| June 30, 2022 | 18.07M |
| March 31, 2022 | 23.11M |
| December 31, 2021 | 14.05M |
| September 30, 2021 | 47.21M |
| June 30, 2021 | 19.58M |
| March 31, 2021 | -0.992M |
| December 31, 2020 | 32.26M |
| September 30, 2020 | 32.02M |
| June 30, 2020 | -24.53M |
| March 31, 2020 | -0.516M |
| December 31, 2019 | 21.41M |
| September 30, 2019 | 16.76M |
| June 30, 2019 | 20.71M |
| March 31, 2019 | 1.481M |
| December 31, 2018 | 18.98M |
| September 30, 2018 | 12.18M |
| June 30, 2018 | 11.08M |
| March 31, 2018 | -7.873M |
| December 31, 2017 | 11.86M |
| Date | Value |
|---|---|
| September 30, 2017 | -8.227M |
| June 30, 2017 | -1.499M |
| March 31, 2017 | -3.61M |
| December 31, 2016 | 12.47M |
| September 30, 2016 | 7.778M |
| June 30, 2016 | -1.327M |
| March 31, 2016 | -10.17M |
| December 31, 2015 | 7.911M |
| September 30, 2015 | -6.787M |
| June 30, 2015 | -4.654M |
| March 31, 2015 | -8.744M |
| December 31, 2014 | 5.899M |
| September 30, 2014 | 4.03M |
| June 30, 2014 | 2.195M |
| March 31, 2014 | -8.544M |
| December 31, 2013 | -9.706M |
| September 30, 2013 | -14.53M |
| June 30, 2013 | -15.05M |
| March 31, 2013 | -16.72M |
| December 31, 2012 | -25.91M |
| September 30, 2012 | -17.44M |
| June 30, 2012 | -24.60M |
| March 31, 2012 | -20.45M |
| December 31, 2011 | -10.08M |
| September 30, 2011 | -10.14M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-24.53M
Minimum
Jun 2020
47.21M
Maximum
Sep 2021
22.77M
Average
21.41M
Median
Dec 2019
Free Cash Flow (Quarterly) Benchmarks
| Dynavax Technologies Corp | 12.04M |
| Arbutus Biopharma Corp | -17.29M |
| Chimerix Inc | -14.59M |
| Karyopharm Therapeutics Inc | -18.58M |
| FibroGen Inc | -18.57M |